VectorBuilder
PrivateLast Round
Series C
Extension
Jul 26, 2023
Est. Valuation
$1B
Total Funding Raised
$76M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
VectorBuilder operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Series C Extension round in July 2023.
VectorBuilder is a biotechnology company that provides a full spectrum of gene delivery solutions, including an online platform for vector design, custom cloning, virus packaging, and CDMO services for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VectorBuilder Comparables
Compare VectorBuilder with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PackGene Biotech | 88% | |
| GenScript | 84% | |
| Charles River Laboratories | 79% |
For institutional investors. Book with your work email.
VectorBuilder Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 26, 2023 | ||||
| Series C | Oct 1, 2022 |
For institutional investors. Book with your work email.
VectorBuilder Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Capital | Series C |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2026
Named "Overall CGT Solution Provider of the Year" at BioTech Breakthrough Awards.
- May 3, 2026
Attending the ARVO Annual Meeting in Denver, Colorado.
For institutional investors. Book with your work email.
VectorBuilder Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VectorBuilder's valuation, stock price, and market status.
Is VectorBuilder a public or private company?
VectorBuilder is a private company.
What is the current stock price of VectorBuilder?
VectorBuilder is a private company, so its shares have no public market price. Caplight tracks VectorBuilder's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VectorBuilder worth (valuation)?
VectorBuilder's valuation is estimated at $1.0B based on funding round data.
Can I buy VectorBuilder stock?
VectorBuilder shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VectorBuilder's last funding round?
VectorBuilder's most recent funding round was Series C Extension on July 26, 2023.
Who are the main investors in VectorBuilder?
Key investors in VectorBuilder include Legend Capital, Guangzhou Yuexiu Industrial Investment Fund Management.
Will VectorBuilder IPO soon?
No public IPO plans have been announced for VectorBuilder.
How can I track VectorBuilder secondary market activity?
Caplight tracks bids, offers, and trades in VectorBuilder's shares on secondary markets.